Pfizer CentreSource (PCS) has finalized supply agreements for selected steroid APIs with Asian contract manufacturers ScinoPharm Taiwan, Ltd. of Tainan, Taiwan and Shanghai Pharmaceutical Co., Ltd. of Shanghai, China. In November 2005 PCS made plans to transfer the manufacture of selected products to Asia as part of an effort to provide customers with an optimal balance of product cost, quality, and regulatory compliance standards. Under the terms of both agreements, Pfizer will transfer th...